Evidence map›Paper›PMID 20130653›Full record

ArticleNature2010

Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers.

Sarah D Cady, Klaus Schmidt-Rohr, Jun Wang, Cinque S Soto, William F Degrado, Mei Hong

Open access · greenAbstract read
In one paragraph

Article in Nature, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 332 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
332citing papers in PubMed, 1 pooled it
37.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

332 citing papers in PubMed, 1 synthesis or guideline pooled it, 629 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Diamond rotors for high magic angle spinning frequencies.Journal of magnetic resonance (San Diego, Calif. : 1997) · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Solid-State NMR of Virus Membrane Proteins.Accounts of chemical research · 2025
    Article
  14. Conformational Analysis of UniformlyMolecules (Basel, Switzerland) · 2025
    Article
  15. The Role of Cholesterol in M2 Clustering and Viral Budding Explained.Journal of chemical theory and computation · 2025
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

272 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sarah D CadyDepartment of Chemistry, Iowa State University, Ames, Iowa 50011 2, USA.
Klaus Schmidt-Rohr
Jun Wang
Cinque S Soto
William F Degrado
Mei Hong
Iowa State University · USUniversity of Pennsylvania · US

Funding

Development of drugs that target the M2 proton channel from the influenza A VirusU01AI074571 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI DEGRADO, WILLIAM · 2008 to 2012
$7.5M
Structures and Dynamics of Proton and Cation-Dependent Channels and TransportersR01GM088204 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI HONG, MEI · 2009 to 2024
$4.8M
Structure of M2 Proton Channel from Influenza A VirusR01GM056423 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI DEGRADO, WILLIAM · 1997 to 2016
$4.5M
NIAID NIH HHS AI74571NIAID NIH HHS U01 AI074571NIGMS NIH HHS GM088204NIGMS NIH HHS GM56423NIGMS NIH HHS R01 GM056423NIGMS NIH HHS R01 GM088204
6 · The paper itself

Abstract

The M2 protein of influenza A virus is a membrane-spanning tetrameric proton channel targeted by the antiviral drugs amantadine and rimantadine. Resistance to these drugs has compromised their effectiveness against many influenza strains, including pandemic H1N1. A recent crystal structure of M2(22-46) showed electron densities attributed to a single amantadine in the amino-terminal half of the pore, indicating a physical occlusion mechanism for inhibition. However, a solution NMR structure of M2(18-60) showed four rimantadines bound to the carboxy-terminal lipid-facing surface of the helices, suggesting an allosteric mechanism. Here we show by solid-state NMR spectroscopy that two amantadine-binding sites exist in M2 in phospholipid bilayers. The high-affinity site, occupied by a single amantadine, is located in the N-terminal channel lumen, surrounded by residues mutated in amantadine-resistant viruses. Quantification of the protein-amantadine distances resulted in a 0.3 A-resolution structure of the high-affinity binding site. The second, low-affinity, site was observed on the C-terminal protein surface, but only when the drug reaches high concentrations in the bilayer. The orientation and dynamics of the drug are distinct in the two sites, as shown by (2)H NMR. These results indicate that amantadine physically occludes the M2 channel, thus paving the way for developing new antiviral drugs against influenza viruses. The study demonstrates the ability of solid-state NMR to elucidate small-molecule interactions with membrane proteins and determine high-resolution structures of their complexes.

Indexed as

AmantadineAmino Acid SequenceAntiviral AgentsBinding SitesCrystallography, X-RayDimyristoylphosphatidylcholineHydrogen-Ion ConcentrationInfluenza A virusLipid BilayersModels, MolecularMolecular Sequence DataNuclear Magnetic Resonance, BiomolecularProtein ConformationStructure-Activity RelationshipTemperatureViral Matrix ProteinsAmantadineAntiviral AgentsDimyristoylphosphatidylcholineLipid BilayersM2 protein, Influenza A virusViral Matrix ProteinsViroporin Proteins

Identifiers

PMID20130653
PMCPMC2818718
OpenAlexW1966438745

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.